These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1195101)

  • 21. Comparative pharmacokinetics of coumarin anticoagulants XXXIII: frequency distribution of dicumarol total clearance in rats.
    Lai CM; Levy G
    J Pharm Sci; 1978 Mar; 67(3):337-40. PubMed ID: 76673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intersubject variation of warfarin binding to protein in serum of normal subjects.
    Yacobi A; Stoll RG; DiSanto AR; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):743-6. PubMed ID: 959669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetics of coumarin anticoagulants. XLIX: Nonlinear tissue distribution of S-warfarin in rats.
    Cheung WK; Levy G
    J Pharm Sci; 1989 Jul; 78(7):541-6. PubMed ID: 2778653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between the dose of warfarin, free drug in plasma, and its elimination in the bile of rats.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):943-50. PubMed ID: 4760900
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative pharmacokinetics of coumarin anticoagulants XXXII: Interindividual differences in binding of warfarin and dicumarol in rat liver and implications for physiological pharmacokinetic modeling.
    Levy G; Lai CM; Yacobi A
    J Pharm Sci; 1978 Feb; 67(2):229-31. PubMed ID: 74408
    [No Abstract]   [Full Text] [Related]  

  • 26. Age-dependent changes in warfarin tissue distribution.
    Kato Y; Hirate J; Sakaguchi K; Ueno M; Horikoshi I
    J Pharmacobiodyn; 1986 Nov; 9(11):889-95. PubMed ID: 3559879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrasubject variation of warfarin binding to protein in serum of patients with cardiovascular disease.
    Yacobi A; Udall JA; Levy G
    Clin Pharmacol Ther; 1976 Sep; 20(3):300-3. PubMed ID: 954352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution pharmacokinetics of warfarin in the rat, a non-linear multicompartment model.
    Kekki M; Julkunen RJ; Wahlström B
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):61-73. PubMed ID: 870833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia.
    Piroli RJ; Passananti GT; Shively CA; Vesell ES
    Clin Pharmacol Ther; 1981 Dec; 30(6):810-6. PubMed ID: 7307430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary excretion of warfarin in rabbits: relationship between pharmacological effect and salivary pharmacokinetics of warfarin in rabbits.
    Sakai K; Nishiura A; Fujihara Y; Kutsuna T; Nishino T
    J Pharmacobiodyn; 1983 Dec; 6(12):991-9. PubMed ID: 6674482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin pharmacokinetics in the horse.
    Thijssen HH; van den Bogaard AE; Wetzel JM; Maes JH; Muller AP
    Am J Vet Res; 1983 Jul; 44(7):1192-6. PubMed ID: 6881659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal distribution of warfarin binding to protein in serum of male-Sprague Dawley rats.
    Slattery JT; Yacobi A; Levy G
    Life Sci; 1976 Aug; 19(3):447-51. PubMed ID: 957882
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for the influence of host factors on warfarin clearance using a single dose single sample procedure.
    Bachmann K
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):167-70. PubMed ID: 3710629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
    Giacomini KM; Blaschke TF
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age as a determinant of sensitivity to warfarin.
    Shepherd AM; Hewick DS; Moreland TA; Stevenson IH
    Br J Clin Pharmacol; 1977 Jun; 4(3):315-20. PubMed ID: 901699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin.
    Williams RL; Schary WL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Jul; 20(1):90-7. PubMed ID: 1277729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.